Randomized Phase 2 Trial of ACP-196 and Pembrolizumab Immunotherapy Dual CHECKpoint Inhibition In Platinum Resistant Metastatic Urothelial Carcinoma (RAPID CHECK Study)
收藏DataCite Commons2025-06-26 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011548/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Metastatic Urothelial Cancer
提供机构：
Vivli
创建时间：
2025-06-26
